Literature DB >> 32368759

The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities.

Emanuel Krebs1, Laura M Dale1, Nosyk B1,2.   

Abstract

Entities:  

Year:  2020        PMID： 32368759      PMCID： PMC7198055     

Source DB:  PubMed          Journal:  HIV Spec


× No keyword cloud information.
  16 in total

Review 1.  Evaluating the public health impact of health promotion interventions: the RE-AIM framework.

Authors:  R E Glasgow; T M Vogt; S M Boles
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

Review 2.  Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities.

Authors:  D Panagiotoglou; M Olding; B Enns; D J Feaster; C Del Rio; L R Metsch; R M Granich; S A Strathdee; B D L Marshall; M R Golden; S Shoptaw; B R Schackman; B Nosyk
Journal:  AIDS Behav       Date:  2018-09

3.  Cost-effectiveness of population-level expansion of highly active antiretroviral treatment for HIV in British Columbia, Canada: a modelling study.

Authors:  Bohdan Nosyk; Jeong E Min; Viviane D Lima; Robert S Hogg; Julio S G Montaner
Journal:  Lancet HIV       Date:  2015-07-16       Impact factor: 12.767

4.  Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study.

Authors:  Linwei Wang; Emanuel Krebs; Jeong E Min; W Christopher Mathews; Ank Nijhawan; Charurut Somboonwit; Judith A Aberg; Richard D Moore; Kelly A Gebo; Bohdan Nosyk
Journal:  Lancet HIV       Date:  2019-07-11       Impact factor: 12.767

5.  Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Authors:  Gillian D Sanders; Ahmed M Bayoumi; Vandana Sundaram; S Pinar Bilir; Christopher P Neukermans; Chara E Rydzak; Lena R Douglass; Laura C Lazzeroni; Mark Holodniy; Douglas K Owens
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

Review 6.  Combination implementation for HIV prevention: moving from clinical trial evidence to population-level effects.

Authors:  Larry W Chang; David Serwadda; Thomas C Quinn; Maria J Wawer; Ronald H Gray; Steven J Reynolds
Journal:  Lancet Infect Dis       Date:  2013-01       Impact factor: 25.071

7.  Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities.

Authors:  Xiao Zang; Emanuel Krebs; Jeong E Min; Ankur Pandya; Brandon D L Marshall; Bruce R Schackman; Czarina N Behrends; Daniel J Feaster; Bohdan Nosyk
Journal:  Med Decis Making       Date:  2019-12-22       Impact factor: 2.583

8.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Gillian D Sanders; Peter J Neumann; Anirban Basu; Dan W Brock; David Feeny; Murray Krahn; Karen M Kuntz; David O Meltzer; Douglas K Owens; Lisa A Prosser; Joshua A Salomon; Mark J Sculpher; Thomas A Trikalinos; Louise B Russell; Joanna E Siegel; Theodore G Ganiats
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272

9.  The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States.

Authors:  Ethan D Borre; Emily P Hyle; A David Paltiel; Anne M Neilan; Paul E Sax; Kenneth A Freedberg; Milton C Weinstein; Rochelle P Walensky
Journal:  J Infect Dis       Date:  2017-10-17       Impact factor: 7.759

10.  Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia.

Authors:  Monica S Ruiz; Allison OʼRourke; Sean T Allen; David R Holtgrave; David Metzger; Jose Benitez; Kathleen A Brady; C Patrick Chaulk; Leana S Wen
Journal:  J Acquir Immune Defic Syndr       Date:  2019-12-01       Impact factor: 3.731
View more
  1 in total

1.  Trends and Characteristics of #HIVPrevention Tweets Posted Between 2014 and 2019: Retrospective Infodemiology Study.

Authors:  Raquel Burgess; Josemari T Feliciano; Leonardo Lizbinski; Yusuf Ransome
Journal:  JMIR Public Health Surveill       Date:  2022-08-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.